From GlobeNewswire:

Kymera Therapeutics, a biopharmaceutical company, will present at the 42nd J.P. Morgan Healthcare Conference in San Francisco on January 9th. A live webcast will be available. They focus on targeted protein degradation to develop medicine for critical health problems, and research for new cancer treatments as well. About Kymera Therapeutics and contact information included.



Read more: Kymera Therapeutics to Present at the 42nd Annual J.P.